Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
上海市通力律师事务所关于科美诊断技术股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 82% confidence The document is a legal opinion letter from an external law firm regarding the convening, attendance and voting procedures and results of the 2025 annual general shareholders meeting. It does not itself constitute the formal company announcement of voting results nor a presentation deck, but rather a compliance/legal opinion document to be included in the meeting materials. It is not a financial report, proxy solicitation statement, nor a formal AGM presentation but a regulatory compliance/legal opinion. Therefore it falls under the fallback category Regulatory Filings (RNS).
2026-05-20 Chinese
科美诊断技术股份有限公司2025年年度股东会会议资料
AGM Information Classification · 100% confidence The document is titled as "2025年年度股东会会议资料" which translates to "2025 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda items for the 2025 AGM, including board reports, profit distribution proposals, audit firm reappointment, director and senior management remuneration proposals, and other governance-related proposals. The document includes meeting instructions, agenda, detailed board reports, and proposals to be voted on at the AGM. It is clearly a set of materials prepared for and used during the Annual General Meeting, not the annual report itself or any other type of filing. The length and content confirm it is the meeting materials, not just an announcement or a brief summary. Therefore, the document fits the category of AGM Information (AGM-R).
2026-05-08 Chinese
科美诊断技术股份有限公司关于召开2025年度暨2026年第一季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of an upcoming performance explanation meeting (业绩说明会) for the 2025 annual and 2026 first quarter results. It provides the meeting time, location, participation method, and contact information. It explicitly states that the company has already released the 2025 annual report and 2026 Q1 report on April 29, 2026, and this meeting is to explain those results and answer investor questions. The document is short (1267 characters) and serves as a notice for an investor presentation event rather than the presentation or report itself. Therefore, it fits the category of Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials, strategy, and market position, conducted via an interactive online meeting.
2026-05-08 Chinese
科美诊断技术股份有限公司关于召开2025年年度股东会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2025 Annual General Meeting (AGM) of the company 科美诊断技术股份有限公司. It includes information about the meeting date, location, voting methods, agenda items to be discussed and voted on, shareholder eligibility, and proxy voting instructions. There is no financial data or report content included, only the announcement and procedural details for the upcoming AGM. The document length is 3675 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2026-04-28 Chinese
科美诊断技术股份有限公司关于2025年度拟不进行利润分配的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from 科美诊断技术股份有限公司 regarding the company's 2025 fiscal year profit distribution plan, specifically stating that no dividends or profit distributions will be made. It includes details about the board meeting approval, profit figures, and compliance with stock exchange listing rules. The document is relatively short (2036 characters) and serves as a formal public notice about the profit distribution decision rather than a full financial report or detailed analysis. It does not contain comprehensive financial statements or detailed management discussion. Therefore, it fits best as a Notice of Dividend Amount (DIV) announcement, even though the notice is about not distributing dividends, it is still a dividend-related announcement.
2026-04-28 Chinese
科美诊断技术股份有限公司独立董事2025年度述职报告（仲人前）（任届期满离任）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for a company, detailing the independent director's duties, attendance, communication with auditors, and opinions on company governance and financial reporting for the year 2025. It includes detailed narrative on the director's activities, committee participation, and evaluations of company practices, but does not contain financial statements or quantitative financial data. It is a narrative report on the independent director's annual duties and observations, which fits the category of Board/Management Information (MANG), as it relates to management and board-level reporting rather than a full annual report or audit report. The document length is under 5,000 characters, but it is a substantive report, not merely an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is MANG with high confidence.
2026-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.